Burden of Sexually Transmitted Infections High in United States
TUESDAY, Jan. 26, 2021 -- The burden of sexually transmitted infections (STIs) is high in the United States, according to a study published online Jan. 23 in Sexually Transmitted Diseases.
Kristen M. Kreisel, Ph.D., from the U.S. Centers for Disease Control and Prevention in Atlanta, and colleagues used new methods to update estimates for the number of prevalent and incident STIs in the United States for 2018. The number of prevalent and incident infections were calculated by multiplying updated per-capita prevalence and incidence estimates for each of eight STIs by the 2018 full resident population estimates.
The researchers identified an estimated 67.6 million prevalent and 26.2 million incident STIs in the United States in 2018. Chlamydia, trichomoniasis, genital herpes, and human papillomavirus comprised 97.6 and 93.1 percent of all prevalent and incident STIs, respectively. Persons aged 15 to 24 years accounted for 18.6 and 45.5 percent of all prevalent and incident infections, respectively.
"At a time when STIs are at an all-time high, they have fallen out of the national conversation," Jonathan Mermin, M.D., M.P.H., from the CDC National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, said in a statement. "There is an urgent need to reverse the trend of increasing STIs, especially in the wake of the COVID-19 pandemic, which has affected many STI prevention services."

© 2021 HealthDay. All rights reserved.
Posted: January 2021
Read this next
USPSTF Urges Screening Young Women for Chlamydia, Gonorrhea
WEDNESDAY, March 3, 2021 -- The U.S. Preventive Services Task Force (USPSTF) recommends screening for chlamydia and gonorrhea for all sexually active women aged 24 years and...
Sexual-Minority Medical Students Have Higher Burnout
WEDNESDAY, Feb. 10, 2021 -- Medical students in sexual-minority groups report increased symptoms of burnout regardless of their perceived experiences of mistreatment, according to...
Single-Drug Regimen Now Advised for Uncomplicated Gonorrhea
TUESDAY, Jan. 5, 2021 -- A single 500-mg intramuscular dose of ceftriaxone is recommended for treatment of uncomplicated urogenital, anorectal, and pharyngeal gonorrhea, according...
More News Resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our Newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.